Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-7568(21)00086-6
PubMed Identifier: 34729547
Publication URI: http://europepmc.org/abstract/MED/34729547
Type: Journal Article/Review
Parent Publication: The Lancet Healthy Longevity
Issue: 6
ISSN: 2666-7568